Loading...
Supriya Lifescience Community
NSEI:SUPRIYA Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 15 Fair Values set on narratives written by author
Community Investing Ideas
Backward Integration And India Sourcing Will Drive Resilient Manufacturing
Key Takeaways Strategic backward integration and tech upgrades enhance operational resilience, margin sustainability, and earnings predictability amid global shifts in pharmaceutical ingredient sourcing. Focus on high-margin specialty APIs, portfolio expansion, and regulatory-compliant products strengthens market position and drives sustained revenue growth from regulated international markets.Read more
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
₹850
12.6% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
26.37% p.a.
Profit Margin
24.97%
Future PE
27.07x
Share price in 2028
₹1.21k
